High-resolution, accurate-mass (HR/AM) capability to expand the company's regulated bioanalysis, drug discovery and metabolism/structural identification services 

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that WIL Research Company, Inc., a global contract-research organization (CRO) providing analytical services to the pharmaceutical industry, selected Thermo Scientific Q Exactive hybrid quadrupole-Orbitrap mass spectrometer systems to expand its capabilities for regulated bioanalysis, drug discovery, metabolism and structural identification services. 

The systems were validated for GLP compliance using Thermo Fisher Scientific Validation Support Services. These services dramatically reduce the overall validation burden by providing test scripts specifically customized for WIL Research's standard operating procedures and system requirements.

"The Q Exactive^TM system offers greater flexibility and simpler operation than our triple quadrupole mass spectrometer systems, and will be extremely effective in addressing our most challenging analytical projects," said Dr.Terry Johnson, Director of Metabolism, WIL Research. "The system's versatility, ruggedness and sensitivity make it very well suited to qualitative drug metabolism, as well as quantitative studies."

The Q Exactive system's unique HR/AM capability will expand the analytical capabilities that WIL Research can provide to its customers. The Q Exactive system is the first commercially available mass spectrometer to bring together quadrupole precursor selection and high-resolution, accurate-mass Orbitrap^TM mass analysis to deliver high-confidence quantitative and qualitative (quan/qual) workflows. With innovative HR/AM Quanfirmation capability, the Q Exactive mass spectrometer makes it possible to identify, quantify and confirm more trace-level drugs, metabolites, peptides and proteins in complex mixtures. Unlike other HR/AM technologies, high-confidence results are obtained without sacrificing quantitative LLOQ's, reproducibility or mass resolution.

For more information about Thermo Scientific mass spectrometry solutions, please call +1 800-532-4752, email analyze@thermofisher.com or visit www.thermoscientific.com/ms.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Thermo Fisher Scientific and Unity^TM Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.
 

About WIL Research Company

WIL Research Company, Inc. is a privately held global Contract Research Organization that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries as well as manufacturing support for clinical trials.